PUBHLTH 1 Lecture Notes - Lecture 5: Aspirin, Polyunsaturated Fat, Framingham Heart Study

44 views3 pages

scarlethyena643

20 Apr 2017

School

Department

Course

Professor

For unlimited access to Class Notes, a Class+ subscription is required.

Document Summary

Epidemiology is the study of the distribution and determinants of disease frequency in human populations. Death is easy to determine - death certificates have cause of death. Some diseases need blood tests or stool cultures to verify diagnosis. Sometimes definition changes as more is learned e. g. aids. Other health outcomes - injuries, risk factors. Count number of people with disease and relate to population at risk (par) Par is a denominator; may be total population or exposed population, or one gender or age group; often comes from census. Prevalence - number of existing cases at a specific time. Incidence is used for studying causes of disease. If causes or risk factors increase, incidence and prevalence increase. If ability to diagnose increases, incidence and prevalence increase. Who - sex, age, occupation, race, etc. When - season, year (long-term trends), elapsed time since an exposure (epidemic curve) Where -neighborhood (e. g. clusters), latitude (climate), urban vs. rural, national variations.

Related Questions

QUESTION 1 1. The relative importance or burden of a disease within a population will depend on a number of factors including : A. Disease frequency B. Disease severity C. Disease consequences D. All of the above

QUESTION 2 1 . With the epidemiologic transition, there is a reduction in malnutrition and _____ . A. Communicable diseases B. Injuries C. Non-communicable chronic diseases D. Mental health disorders

QUESTION 3 1. A major challenge to developing a burden of disease profile in low and middle-income countries relates to A. Unwillingness to share complete information B. Conflicting disease definitions C. Challenges obtaining information related to cause of death D. All of the above

QUESTION 4 1. The demographic transition describes which of the following changes to society A. Changes in birth and death rates that reflect a modern society B. Declines in mortality followed by a reduction in fertility C. A change in the age structure of the population D. All of the above

QUESTION 5 1. Measures of health status that combine mortality and morbidity data A. Facilitate comparisons both within and across populations B. Help estimate the quantitative health benefits from interventions C. Serve as tools to assist with resource allocation D. All of the above

QUESTION 6 1. The disability-adjusted life year is defined as A. A health gap population summary measure that combines time lost due to disability with that lost due to death B. A measure to compare the gap between the current situation to that of an ideal situation C. A measure that combines the amount of healthy life lost due to morbidity with that lost due to injury. D. Answers B and C

QUESTION 7 1. True or false? A key limitation to mortality-based indicators is that they fail to account for the morbidity caused by disease. True False

QUESTION 8 1. The most widely used composite measure of population health is the DALY, and this epidemiological measure is the sum of morbidity and ________data. A. Years of life lost (YLL) B. Morbidity C. Infant mortality rates (IMR) D. none of the above

QUESTION 9 1. What would be the best source of information on adult and infant mortality (in high income countries)? A. Disease registers B. Vital statistics C. Special survey study D. Hospital clinic statistics

QUESTION 10 1. Which term is best used to describe the proportion of people in a population who have a defined disease at a specific point of time? A. DALY B. Incidence C. Mortality rate D. Prevalence

QUESTION 11 1. Which term is best used to describe new cases of disease occurring in a population? A. DALY B. Incidence C. Mortality rate D. Prevalence

QUESTION 12 1. Which term is used to describe the absence or presence of illness or disease? A. Demography B. Morbidity C. Mortality D. Vitality

QUESTION 13 1. Mortality (death indicators) include: A. Mortality rate B. Infant mortality rate C. Neonatal morality rate D. All of the above

QUESTION 14 1. True or false? The value of life is often implicit in the way resource allocation decisions are made, which suggests that these decisions should be as explicit, open, and transparent as possible. True False

QUESTION 15 1. _________________is projected as the number one leading cause of disease burden in 2030. A. Ischemic heart disease B. Diabetes mellitus C. HIV/AIDS D. Unipolar depression

QUESTION 16 1. Some of the negative aspects of globalization include A. Greater insecurity of employment B. Poorer housing and sanitation due to rapid urbanization C. Greater vulnerability to environmental degradation D. All of the above

QUESTION 17 1. Current concerns about climate change focus on several developments including A. Rising global average land and sea surface temperature B. Increasing frequency of extreme weather conditions C. Both A and B D. None of the above

QUESTION 18 1. True or false? Diseases carried by mosquitoes are especially sensitive to meteorological conditions because they are vulnerable to changes in the ambient temperature. As a result of changing temperatures, infectious diseases such as malaria and dengue have decreased in incidence and geographic range. True False

QUESTION 19 1. True or false? International cooperation of infectious disease control has a long history that includes obligatory reporting of outbreaks of specific diseases. However, compliance with obligatory reporting has been poor due to economic consequences that have often accompanied notification of disease outbreaks. True False

QUESTION 20 1. True or false? Globalization is a relatively new phenomenon that began in the mid-20th century. True False

1. The risk of acquiring disease is measured by the

a. Incidence rate

b. Incidence rate times the average duration of the disease

c. Incidence rate divided by the prevalence rate

d. Prevalence rate

e. Prevalence rate times the average duration of the disease

2. The strength of an association between a factor and a disease is best measure by .

a. Incubation rate

b. Incidence of the disease in the total population

c. Prevalence of the factor

d. Attributable risk

e. Relative risk

3. Case fatality rate for a given disease refers to

a. The crude mortality rate per 100,000 population

b. Cause-specific mortality rate due to the disease

c. A fatal outcome of any disease

d. The percentage of deaths among cases of the disease

e. The proportion of deaths due to the disease among all deaths from all causes

4. An investigator is interested in etiology of neonatal jaundice. To study this condition, he selected 100 children who were diagnosed with this condition and 100 children born in the same period and in the same hospital who did not have a diagnosis of neonatal jaundice. He then reviewed the obstetrical and delivery records of their mothers to determine various prenatal and perinatal exposures. This is an example of a(n):

a. Cross-sectional study

b. Case-control study

c. Cohort study

d. Clinical trial

e. Experiment

5. Which of the following statements describes the major advantages of a randomized clinical trial?

a. It avoids observer bias

b. It lends itself to ethical justification

c. It yields results replicable in other patients

d. It rules out self-selection of participants to the different treatment groups

d. It enrolls representative patients

6. A survey conducted in England revealed that of 224 families in which there had been a known case of poliomyelitis, 56 maintained parakeets as a family pet. In another British survey, 30 out of 99 poliomyelitis patients questioned kept parakeets. The inference that there is some relationship between the presence of a parakeet in a household and the occurrence of poliomyelitis among household members is

a. Correct b.

Incorrect because of failure to distinguish between incidence and prevalence

c. Incorrect because a proportionate ratio is used when a rate is required to support the inference

d. Incorrect because a failure to recognize a possible cohort phenomenon

e. Incorrect because there is no control or comparison group.

7. An investigator determines the correlation coefficient between triglyceride levels and degree of atherosclerosis in sampled blood vessels to be +1.67. On the basis of this you would conclude that:

a. Triglyceride level is a good predictor of atherosclerosis

b. Triglyceride level is not a good predictor of atherosclerosis

c. High triglyceride levels cause atherosclerosis

d. Atherosclerosis cause high triglyceride levels

e. The investigator has incorrectly determined the correlation coefficient

8. A screening test of known sensitivity and specificity is applied to two populations. The prevalence of the disease being screened for is 10% in population A and is 1% in population B. Which of the following is true?

a. The percent of all negative tests that have false-negative results is lower in population A than in population B.

b. Specificity is lower in population A than in population B.

c. Reliability is higher in population A than in population B.

d. The percent of all positive tests that have false-positive results is lower in population A than in population B.

e. Specificity is higher in population A than in population B.

9. Serum cholesterol levels are obtained for four healthy men. The probability that all will fall below the 10th percentile of the distribution of cholesterol for healthy males is:

a. 0.4

b. 1 â (0.1)4

c. (0.1)4

d. (0.9)4

e. Cannot be determined from these data

10. In a diabetes screening program, the screening level for a positive blood sugar level in test 1 is set at 160 mg/dl, and in test 2 at 130 mg/dl. The sensitivity is:

a. Greater in test 1

b. Greater in test 2

c. Equal in test 1 and 2

d. Dependent on the size of the population being evaluated

Please, help me answer the following questions on Chronic Diseases and Risks. No guess work, thank you!

QUESTION 1 Chronic diseases generally have several underlying characteristics, including a. A long latency period between exposure to risk and disease outcomes b. Low degree of preventability c. High curve rate d. None of the above

QUESTION 2 Which of the following risk factors collectively explain a significant proportion (not incidence) of most chronic diseases? a. Tobacco, alcohol, diet

b. Tobacco, alcohol, diet, physical activity c. Alcohol, physical activity d. Tobacco, diet, physical activity

QUESTION 3 Adherence to treatment is influenced by several interacting dimensions including a. Social and economic factors b. Healthcare system factors c. Condition-related factors

d. Therapy-related factors e. Patient related factors f. All of the above

QUESTION 4 _________ is the leading cause of cancer in both developed and developing countries worldwide a. Radiation exposure b. Tobacco use c. Pesticide exposure d. Air pollution QUESTION 5 This week's YouTube video on treating non-communicable diseases in Rwanda showed how a community health worker helps to treat heart disease, diabetes and _______ a. Cancer b. Asthma c. Hepatitis d. HIV/AIDS

QUESTION 6 Which of these are myths of chronic disease control a. Benefits of chronic disease control accrue not only to the individual but also to the population b. Economic growth improves all health conditions c. Chronic diseases are associated with low SES/poverty d. Chronic disease only occurs in the elderly e. a and c f. b and d

QUESTION 7 ___________ remains the leading cause of death among both men and women in low- and middle-income countries a. Cancer b. Cardiovascular disease c. Diabetes d. Obesity e. Respiratory disease

QUESTION 8 Chronic disease in adults accounts for approximately 60% of all deaths worldwide. True False

QUESTION 9 The WHO's Innovative Care for Chronic Conditions Framework includes a positive policy environment True False

QUESTION 10 It is estimated that the overall number of cancer cases will rise by 50% in the next 20 years. True False

periwinkleskunk371

PUBHLTH 1 Lecture Notes - Lecture 5: Aspirin, Polyunsaturated Fat, Framingham Heart Study

Document Summary

Get access

Related Documents

PUBHLTH 1 Lecture Notes - Lecture 9: Dental Caries, Field Trial, Cohort Study

PUBHLTH 1 Lecture Notes - Lecture 8: Cohort Study, Field Trial, Polio Vaccine

PUBHLTH 1 Lecture Notes - Lecture 8: Cohort Study, Aspirin, Cluster Headache

Related Questions